Patent Expiration to Propel the Global Biosimilar and Follow-on Biologics Market During the Forecast Period
One of the main factors driving the global biosimilar and follow-on biologics market is patent expiration. The expansion of the follow-on biologics market can be attributed to various regulatory and commercial developments that are taking place today. The demand for cost-effective biological drugs is on the rise, which is why manufacturers these days prefer manufacturing biopharmaceuticals drugs that are generic. This enables manufacturers to ensure that these life saving drugs are priced competitively.
View full press release